Browsing: test

The U.S. Food and Drug Administration (FDA) has cleared for marketing an innovative blood test with underlying technology invented at Washington University School of Medicine in St. Louis for the early diagnosis of Alzheimer’s disease. The test, known as PrecivityAD2, was developed and validated by C2N Diagnostics, a WashU startup company

Oslo, 20 August 2026:  CEPI is providing US$4.17 million to four research projects designed to assess whether vaccines already or previously licensed against Zaire ebolavirus—including Ervebo—could offer protection against Bundibugyo ebolavirus, the virus behind the rapidly escalating outbreak in the Democratic Republic of the Congo, which was declared a Public Health Emergency of International Concern…